<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v3.0 20080202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing3.dtd?><?SourceDTD.Version 3.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Oncol Lett</journal-id><journal-id journal-id-type="iso-abbrev">Oncol Lett</journal-id><journal-id journal-id-type="publisher-id">OL</journal-id><journal-title-group><journal-title>Oncology Letters</journal-title></journal-title-group><issn pub-type="ppub">1792-1074</issn><issn pub-type="epub">1792-1082</issn><publisher><publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5104197</article-id><article-id pub-id-type="doi">10.3892/ol.2016.5161</article-id><article-id pub-id-type="publisher-id">OL-0-0-5161</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Comparative analysis of gene expression profiles of gastric cardia adenocarcinoma and gastric non-cardia adenocarcinoma</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Song</surname><given-names>Bin</given-names></name><xref ref-type="aff" rid="af1-ol-0-0-5161">1</xref></contrib><contrib contrib-type="author"><name><surname>Du</surname><given-names>Juan</given-names></name><xref ref-type="aff" rid="af2-ol-0-0-5161">2</xref></contrib><contrib contrib-type="author"><name><surname>Deng</surname><given-names>Neng</given-names></name><xref ref-type="aff" rid="af1-ol-0-0-5161">1</xref></contrib><contrib contrib-type="author"><name><surname>Ren</surname><given-names>Ji-Chen</given-names></name><xref ref-type="aff" rid="af2-ol-0-0-5161">2</xref></contrib><contrib contrib-type="author"><name><surname>Shu</surname><given-names>Zhen-Bo</given-names></name><xref ref-type="aff" rid="af1-ol-0-0-5161">1</xref><xref rid="c1-ol-0-0-5161" ref-type="corresp"/></contrib></contrib-group><aff id="af1-ol-0-0-5161"><label>1</label>Department of Gastrointestinal Surgery, China-Japan Union Hospital, Jilin University, Changchun, Jilin 130033, P.R. China</aff><aff id="af2-ol-0-0-5161"><label>2</label>Second Department of Internal Medicine, The Tumor Hospital of Jilin, Changchun, Jilin 130012, P.R. China</aff><author-notes><corresp id="c1-ol-0-0-5161"><italic>Correspondence to</italic>: Mr. Zhen-Bo Shu, Department of Gastrointestinal Surgery, China-Japan Union Hospital, Jilin University, 126 Xiantai Street, Changchun, Jilin 130033, P.R. China, E-mail: <email>shuzhenbo@sina.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>11</month><year>2016</year></pub-date><pub-date pub-type="epub"><day>21</day><month>9</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>21</day><month>9</month><year>2016</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>12</volume><issue>5</issue><fpage>3866</fpage><lpage>3874</lpage><history><date date-type="received"><day>24</day><month>4</month><year>2015</year></date><date date-type="accepted"><day>04</day><month>8</month><year>2016</year></date></history><permissions><copyright-statement>Copyright: &#169; Song et al.</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license></permissions><abstract><p>In the present study, gene expression profiles were analyzed to identify the molecular mechanisms underlying gastric cardia adenocarcinoma (GCA) and gastric non-cardia adenocarcinoma (GNCA). A gene expression dataset (accession number GSE29272) was downloaded from Gene Expression Omnibus, and consisted of 62 GCA samples and 62 normal controls, as well as 72 GNCA samples and 72 normal controls. The two groups of differentially-expressed genes (DEGs) were compared to obtain common and unique DEGs. A differential analysis was performed using the Linear Models for Microarray Data package in R. Functional enrichment analysis was conducted for the DEGs using the Database for Annotation, Visualization and Integrated Discovery. Protein-protein interaction (PPI) networks were constructed for the DEGs with information from the Search Tool for the Retrieval of Interacting Genes. Subnetworks were extracted from the whole network with Cytoscape. Compared with the control, 284 and 268 genes were differentially-expressed in GCA and GNCA, respectively, of which 194 DEGs were common between GCA and GNCA. Common DEGs [e.g., claudin (CLDN)7, CLDN4 and CLDN3] were associated with cell adhesion and digestion. GCA-unique DEGs [e.g., MAD1 mitotic arrest deficient like 1, cyclin (CCN)B1, CCNB2 and CCNE1] were associated with the cell cycle and the regulation of cell proliferation, while GNCA-unique DEGs (e.g., GATA binding protein 6 and hyaluronoglucosaminidase 1) were implicated in cell death. A PPI network with 141 nodes and 446 edges were obtained, from which two subnetworks were extracted. Genes [e.g., fibronectin 1, collagen type I &#945;2 chain (COL1A2) and COL1A1] from the two subnetworks were implicated in extracellular matrix organization. These common DEGs could advance our understanding of the etiology of gastric cancer, while the unique DEGs in GCA and GNCA could better define the properties of specific cancers and provide potential biomarkers for diagnosis, prognosis or therapy.</p></abstract><kwd-group><kwd>gastric cardia adenocarcinoma</kwd><kwd>gastric non-cardia adenocarcinoma</kwd><kwd>gene expression data</kwd><kwd>differentially-expressed genes</kwd><kwd>functional enrichment analysis</kwd><kwd>protein-protein interaction network</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Gastric cancer is the third leading cause of cancer-associated mortality (<xref rid="b1-ol-0-0-5161" ref-type="bibr">1</xref>). The most common cause of gastric cancer is infection by the bacteria <italic>Helicobacter pylori</italic>, which accounts for ~60% of cases (<xref rid="b1-ol-0-0-5161" ref-type="bibr">1</xref>,<xref rid="b2-ol-0-0-5161" ref-type="bibr">2</xref>). Smoking also increases the risk significantly. The prognosis of stomach cancer is generally poor due to the fact that the tumor has often metastasized by the time of diagnosis (<xref rid="b3-ol-0-0-5161" ref-type="bibr">3</xref>), which makes it necessary to identify biomarkers for an early diagnosis.</p><p>Stomach cancers are overwhelmingly adenocarcinomas. Gastric adenocarcinomas are a heterogeneous group of tumors. The cardia lies between the end of the esophagus and the body of the stomach, and is a small macroscopically indistinct zone that lies immediately distal to the gastroesophageal junction. Gastric cardia adenocarcinoma (GCA) and esophageal squamous cell carcinoma (ESCC) share certain etiological risk factors. Abnet <italic>et al</italic> reported a shared susceptibility locus in PLCE1 at 10q23 for GCA and ESCC (<xref rid="b4-ol-0-0-5161" ref-type="bibr">4</xref>). GCA may have a distinct etiology. Substantially higher TP53 mutation rates have been detected in cases with GCA than gastric non-cardia adenocarcinoma (GNCA) (<xref rid="b5-ol-0-0-5161" ref-type="bibr">5</xref>). Kamangar <italic>et al</italic> indicated that <italic>H. pylori</italic> is a strong risk factor for non-cardia gastric cancer, but that it is inversely associated with the risk of gastric cardia cancer (<xref rid="b6-ol-0-0-5161" ref-type="bibr">6</xref>). Kim <italic>et al</italic> found differences in the clinicopathology and protein expression in cardia carcinoma and non-cardia carcinoma (<xref rid="b7-ol-0-0-5161" ref-type="bibr">7</xref>).</p><p>Although a number of genetic alterations have been identified in gastric cancer, including those in cadherin 1 (CDH1) (<xref rid="b8-ol-0-0-5161" ref-type="bibr">8</xref>,<xref rid="b9-ol-0-0-5161" ref-type="bibr">9</xref>), &#946;-catenin (<xref rid="b10-ol-0-0-5161" ref-type="bibr">10</xref>), CDH17 (<xref rid="b11-ol-0-0-5161" ref-type="bibr">11</xref>) and Met (<xref rid="b12-ol-0-0-5161" ref-type="bibr">12</xref>), no study has distinguished these alterations by anatomical subsite. A number of previous gene expression profiling studies have also ignored the differences in diverse anatomical subsite (<xref rid="b11-ol-0-0-5161" ref-type="bibr">11</xref>,<xref rid="b13-ol-0-0-5161" ref-type="bibr">13</xref>,<xref rid="b14-ol-0-0-5161" ref-type="bibr">14</xref>), such as in GCA and GNCA. Therefore, a comparative analysis of the gene expression profiles of GCA and GNCA would provide more accurate and valuable information on GCA.</p><p>Based upon the gene expression data from Wang <italic>et al</italic> (<xref rid="b15-ol-0-0-5161" ref-type="bibr">15</xref>), the present study adopted functional enrichment analysis and protein-protein interaction (PPI) network analysis to obtain a greater understanding of the common pathogenesis of GCA and GNCA, as well as the unique molecular mechanisms underlying GCA and GNCA, which could facilitate the development of targeted strategies for early detection, prognosis, and therapy.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><sec><title/><sec><title>Gene expression data</title><p>A gene expression dataset (access number GSE29272) (<xref rid="b15-ol-0-0-5161" ref-type="bibr">15</xref>) was downloaded from Gene Expression Omnibus (<uri xlink:type="simple" xlink:href="http://www.ncbi.nlm.nih.gov/geo/">http://www.ncbi.nlm.nih.gov/geo/</uri>), and consisted of 62 GCA samples and 62 normal controls, as well as 72 GNCA samples and 72 normal controls. Gene expression levels were measured using the Affymetrix Human Genome U133A Array (Affymetrix Inc., Santa Clara, CA, USA).</p></sec><sec><title>Pre-treatment and differential analysis</title><p>Raw data were treated with the Robust Multi-array Analysis method from the Affy package (<xref rid="b16-ol-0-0-5161" ref-type="bibr">16</xref>). Values of probes mapping to a same Entrez gene ID were averaged as a final expression level for the specific gene. A total of 22,283 probes and 12,495 genes were obtained.</p><p>Differential analysis was performed with the Linear Models for Microarray Data (<xref rid="b17-ol-0-0-5161" ref-type="bibr">17</xref>) in R to identify DEGs in GCA and GNCA. The cut-offs were set as |log (fold change)|&gt;1 and a P-value of &lt;0.01. Overlapping DEGs of GCA and GNCA, as well as unique DEGs, were further selected out.</p></sec><sec><title>Functional enrichment analysis</title><p>Gene Ontology (GO; <uri xlink:type="simple" xlink:href="http://www.geneontology.org/">http://www.geneontology.org/</uri>) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (<uri xlink:type="simple" xlink:href="http://www.genome.jp/kegg">http://www.genome.jp/kegg</uri>) pathway enrichment analysis were applied on the overlapping DEGs and unique DEGs using the Database for Annotation, Visualization and Integration Discovery (<uri xlink:type="simple" xlink:href="http://david.abcc.ncifcrf.gov/">http://david.abcc.ncifcrf.gov/</uri>) online tool (<xref rid="b18-ol-0-0-5161" ref-type="bibr">18</xref>). P&lt;0.05 was set as the threshold.</p></sec><sec><title>Construction of the PPI network</title><p>A PPI network was constructed for the overlapping DEGs using information from the Search Tool for the Retrieval of Interacting Genes (<xref rid="b19-ol-0-0-5161" ref-type="bibr">19</xref>). Interactions with a score of &gt;0.4 were retained and then visualized by Cytoscape (<xref rid="b20-ol-0-0-5161" ref-type="bibr">20</xref>). The proteins in the network serve as the &#8216;nodes&#8217;, and each pairwise protein interaction is represented by an undirected link and the degree of a node corresponds to the number of interactions of a protein. Degree was calculated for each node. Hub genes were then selected out according to the degree.</p><p>Subnetworks were also identified by Cytoscape (<xref rid="b20-ol-0-0-5161" ref-type="bibr">20</xref>) and its plugin MCODE (<xref rid="b21-ol-0-0-5161" ref-type="bibr">21</xref>), on which functional enrichment analysis was then applied.</p></sec></sec></sec><sec sec-type="results"><title>Results</title><sec><title/><sec><title>Differentially-expressed genes (DEGs)</title><p>Gene expression data of GCA and GNCA prior to and after normalization are shown in <xref rid="f1-ol-0-0-5161" ref-type="fig">Figs. 1</xref> and <xref rid="f2-ol-0-0-5161" ref-type="fig">2</xref>. A good performance of normalization was achieved.</p><p>A total of 284 DEGs, 151 upregulated and 133 downregulated, were identified in GCA, while 268 DEGs, 126 upregulated and 142 downregulated, were revealed in GNCA. A total of 194 DEGs, 90 upregulated and 104 downregulated, were common between GCA and GNCA (<xref rid="f3-ol-0-0-5161" ref-type="fig">Fig. 3</xref>).</p></sec><sec><title>Functional enrichment analysis result</title><p>Functional enrichment analysis was performed for the overlapping DEGs and unique DEGs. As shown in <xref rid="tI-ol-0-0-5161" ref-type="table">Table I</xref>, upregulated overlapping DEGs were involved in cell adhesion, the response to wounding and the regulation of cell proliferation. Extracellular matrix (ECM)-receptor interaction and focal adhesion were significantly over-represented. As for downregulated overlapping DEGs, digestion, oxidation reduction and the homeostatic process were enriched. The DEGs were associated with the metabolism of xenobiotics by cytochrome P450 and nitrogen metabolism.</p><p>GCA-unique DEGs were closely associated with the cell cycle and the regulation of cell proliferation (<xref rid="tII-ol-0-0-5161" ref-type="table">Table II</xref>). Pathways such as the cell cycle, the p53 signaling pathway and the Toll-like receptor signaling pathway were enriched (<xref rid="tII-ol-0-0-5161" ref-type="table">Table II</xref>).</p><p>GNCA-unique DEGs were implicated in the regulation of angiogenesis, cell death and small GTPase-mediated signal transduction (<xref rid="tIII-ol-0-0-5161" ref-type="table">Table III</xref>). Pathways such as focal adhesion and vascular smooth muscle contraction were enriched (<xref rid="tIII-ol-0-0-5161" ref-type="table">Table III</xref>).</p></sec><sec><title>PPI network</title><p>A PPI network was constructed for the overlapping DEGs (<xref rid="f4-ol-0-0-5161" ref-type="fig">Fig. 4</xref>), including 141 nodes and 446 edges.</p><p>Subnetwork 1 consisting of nodes with a degree &gt;10 were extracted from the whole network (<xref rid="f5-ol-0-0-5161" ref-type="fig">Fig. 5</xref>). The subnetwork contained 14 nodes and 75 edges. Three hub genes with a degree &gt;25 were identified: Fibronectin 1 (FN1), collagen type I &#945;2 (COL1A2) and COL1A1. The degrees of connectivity were 38, 28 and 26, respectively. The 3 hub genes interacted with each other and their neighboring nodes were selected as subnetwork 2, which included 45 nodes and 245 edges (<xref rid="f5-ol-0-0-5161" ref-type="fig">Fig. 5</xref>).</p><p>Functional enrichment analysis was performed for the genes in the two subnetworks (<xref rid="tIV-ol-0-0-5161" ref-type="table">Tables IV</xref> and <xref rid="tV-ol-0-0-5161" ref-type="table">V</xref>). GO enrichment analysis showed that the genes in subnetwork 1 were associated with collagen fibril organization, ECM organization and cell adhesion (<xref rid="tIV-ol-0-0-5161" ref-type="table">Table IV</xref>). ECM-receptor interaction and focal adhesion were significantly enriched (<xref rid="tIV-ol-0-0-5161" ref-type="table">Table IV</xref>). As for genes from subnetwork 2, they were involved in ECM organization, cell adhesion and extracellular structure organization (<xref rid="tV-ol-0-0-5161" ref-type="table">Table V</xref>). ECM-receptor interaction, focal adhesion, and complement and coagulation cascades were enriched (<xref rid="tV-ol-0-0-5161" ref-type="table">Table V</xref>).</p></sec></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>A comparative analysis of gene expression data of GCA and GNCA was performed in the present study. A total of 284 DEGs were identified in GCA, while 268 DEGs were revealed in GNCA. As many as 194 DEGs were shared by GCA and GNCA, while 90 DEGs were unique in GCA.</p><p>Upregulated common DEGs were involved in cell adhesion and the regulation of cell proliferation. Several members of the claudin family were revealed, including claudin 7 (CLDN7), CLDN4 and CLDN3. CLDN7 expression is an early event in gastric tumorigenesis (<xref rid="b22-ol-0-0-5161" ref-type="bibr">22</xref>). Zavala-Zendejas <italic>et al</italic> also reported that the overexpression of CLDN7 in the human gastric adenocarcinoma AGS cell line increased its invasiveness, migration and proliferation rate (<xref rid="b23-ol-0-0-5161" ref-type="bibr">23</xref>). CLDN4 and CLDN3 may also play roles in the pathogenesis of gastric cancer. Cadherin 11 (CDH11) and CDH17 were also found to be upregulated in GCA and GNCA in the present study. CDH17 is reported as a prognostic marker in early-stage gastric cancer (<xref rid="b11-ol-0-0-5161" ref-type="bibr">11</xref>). Zhang <italic>et al</italic> blocked the proliferation and migration of gastric cancer via targeting CDH17 with an artificial microRNA (<xref rid="b24-ol-0-0-5161" ref-type="bibr">24</xref>), suggesting that CDH17 is a potential target for the control of gastric cancer progression. In the present study, downregulated common DEGs were associated with digestion and metabolism, suggesting that the function of the stomach was impaired by the cancer. Several enzymes were included in the affected list, such as progastricsin, calpain 9 and aldo-keto reductase family 1 member C2. Mucin 6 (MUC6) and MUC5AC, playing essential roles in epithelial cytoprotection from acids and proteases, were also downregulated.</p><p>In the present study, a PPI network, including 141 nodes and 446 edges, was constructed for the common DEGs, from which two subnetworks were disclosed. Genes from the two subnetworks were associated with cell adhesion and ECM organization. The ECM provides a microenvironment for cell proliferation, cell adhesion and cell motion, and thus plays a critical role in cancer development (<xref rid="b25-ol-0-0-5161" ref-type="bibr">25</xref>) and metastasis (<xref rid="b26-ol-0-0-5161" ref-type="bibr">26</xref>). FN1, COL1A2 and COL1A1 were the top 3 hub genes in the whole network. FN1 is involved in cell adhesion and migration processes such as metastasis. David <italic>et al</italic> found that fibronectin expression is significantly associated with the expanding growth pattern of the gastric cancer (<xref rid="b27-ol-0-0-5161" ref-type="bibr">27</xref>). Yang <italic>et al</italic> found that Twist regulates cell motility and invasion in gastric cancer cell lines through N-cadherin and fibronectin production (<xref rid="b28-ol-0-0-5161" ref-type="bibr">28</xref>).</p><p>GCA-unique DEGs were implicated in the cell cycle and the regulation of cell proliferation in the present study. MAD1 mitotic arrest deficient-like 1 (MAD1L1) is a component of the mitotic spindle-assembly checkpoint that prevents the onset of anaphase until all chromosomes are properly aligned at the metaphase plate, and it may play a role in cell cycle control and tumor suppression. Coe <italic>et al</italic> report that MAD1L1 is the most frequent copy number gain in small cell lung cancer cell lines (<xref rid="b29-ol-0-0-5161" ref-type="bibr">29</xref>). Guo <italic>et al</italic> further suggested that genetic variants in MAD1L1 and MAD2L1 confer a susceptibility to lung cancer, which may result from reduced spindle checkpoint function due to the attenuated function of MAD1L1 and/or MAD2L1 (<xref rid="b30-ol-0-0-5161" ref-type="bibr">30</xref>). We supposed that MAD1L1 had a similar role in the pathogenesis of GCA. Three members of the cyclin family, CCNB1, CCNB2 and CCNE1, were also found to be upregulated in GCA. The B-type cyclins, CCNB1 and CCNB2, associate with p34cdc2 and are essential components of the cell cycle regulatory machinery. Begnami <italic>et al</italic> found that the expression of cyclin B1 is associated with regional lymph node metastasis and a poor prognosis in gastric cancer (<xref rid="b31-ol-0-0-5161" ref-type="bibr">31</xref>).</p><p>GNCA-unique DEGs were found to be associated with cell death in the present study. Abnormalities in cell death are closely associated with tumorigenesis. The GATA family of transcription factors participates in gastrointestinal development. GATA binding protein 6 (GATA6) is shown to be expressed in gastric cancer; it activates the expression of gastroprotective trefoil genes, trefoil factor 1 (TFF1) and TFF2 (<xref rid="b32-ol-0-0-5161" ref-type="bibr">32</xref>). Haveri <italic>et al</italic> further reported that GATA6 expression is altered in neoplastic human gastrointestinal mucosa (<xref rid="b33-ol-0-0-5161" ref-type="bibr">33</xref>), suggesting that it may play a role in tumor progression. Hyaluronoglucosaminidase 1 (HYAL1) is a lysosomal hyaluronidase. Hyaluronan is believed to be involved in cell proliferation, migration and differentiation. HYAL1 is suggested to exhibit prognostic potential in prostate cancer (<xref rid="b34-ol-0-0-5161" ref-type="bibr">34</xref>). The study by Lokeshwar <italic>et al</italic> showed that, depending on the concentration, HYAL1 functions as a tumor promoter or as a suppressor in prostate cancer (<xref rid="b35-ol-0-0-5161" ref-type="bibr">35</xref>). We speculated that it may exert a similar function in the progression of GNCA.</p><p>Overall, in the present study, a number of common DEGs were identified in GCA and GNCA, which could advance our understanding of the etiology of gastric cancer. Furthermore, DEGs unique to GCA and to GNCA were identified, which supplemented our knowledge on the pathogenetic mechanisms involved and provided potential biomarkers for the diagnosis, prognosis or treatment of the disease.</p></sec></body><back><ref-list><title>References</title><ref id="b1-ol-0-0-5161"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fock</surname><given-names>KM</given-names></name><name><surname>Ang</surname><given-names>TL</given-names></name></person-group><article-title>Epidemiology of Helicobacter pylori infection and gastric cancer in Asia</article-title><source>J Gastroenterol Hepatol</source><volume>25</volume><fpage>479</fpage><lpage>486</lpage><year>2010</year><pub-id pub-id-type="doi">10.1111/j.1440-1746.2009.06188.x</pub-id><?supplied-pmid 20370726?><pub-id pub-id-type="pmid">20370726</pub-id></element-citation></ref><ref id="b2-ol-0-0-5161"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plummer</surname><given-names>M</given-names></name><name><surname>Franceschi</surname><given-names>S</given-names></name><name><surname>Vignat</surname><given-names>J</given-names></name><name><surname>Forman</surname><given-names>D</given-names></name><name><surname>de Martel</surname><given-names>C</given-names></name></person-group><article-title>Global burden of gastric cancer attributable to Helicobacter pylori</article-title><source>Int J Cancer</source><volume>136</volume><fpage>487</fpage><lpage>490</lpage><year>2015</year><pub-id pub-id-type="doi">10.1002/ijc.28999</pub-id><?supplied-pmid 24889903?><pub-id pub-id-type="pmid">24889903</pub-id></element-citation></ref><ref id="b3-ol-0-0-5161"><label>3</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wilkinson</surname><given-names>N</given-names></name></person-group><chapter-title>Management of gastric cancer</chapter-title><source>Surgical Oncology Clinics</source><publisher-name>Saunders</publisher-name><publisher-loc>Philadelphia, PA</publisher-loc><year>2012</year><pub-id pub-id-type="doi">10.1245/s10434-012-2412-5</pub-id><?supplied-pmid 22098840?></element-citation></ref><ref id="b4-ol-0-0-5161"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abnet</surname><given-names>CC</given-names></name><name><surname>Freedman</surname><given-names>ND</given-names></name><name><surname>Hu</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Yu</surname><given-names>K</given-names></name><name><surname>Shu</surname><given-names>XO</given-names></name><name><surname>Yuan</surname><given-names>JM</given-names></name><name><surname>Zheng</surname><given-names>W</given-names></name><name><surname>Dawsey</surname><given-names>SM</given-names></name><name><surname>Dong</surname><given-names>LM</given-names></name><etal/></person-group><article-title>A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma</article-title><source>Nat Genet</source><volume>42</volume><fpage>764</fpage><lpage>767</lpage><year>2010</year><pub-id pub-id-type="doi">10.1038/ng.649</pub-id><?supplied-pmid 20729852?><pub-id pub-id-type="pmid">20729852</pub-id></element-citation></ref><ref id="b5-ol-0-0-5161"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gleeson</surname><given-names>CM</given-names></name><name><surname>Sloan</surname><given-names>JM</given-names></name><name><surname>McManus</surname><given-names>DT</given-names></name><name><surname>Maxwell</surname><given-names>P</given-names></name><name><surname>Arthur</surname><given-names>K</given-names></name><name><surname>McGuigan</surname><given-names>JA</given-names></name><name><surname>Ritchie</surname><given-names>AJ</given-names></name><name><surname>Russell</surname><given-names>SE</given-names></name></person-group><article-title>Comparison of p53 and DNA content abnormalities in adenocarcinoma of the oesophagus and gastric cardia</article-title><source>Br J Cancer</source><volume>77</volume><fpage>277</fpage><lpage>286</lpage><year>1998</year><pub-id pub-id-type="doi">10.1038/bjc.1998.44</pub-id><?supplied-pmid 9460999?><pub-id pub-id-type="pmid">9460999</pub-id></element-citation></ref><ref id="b6-ol-0-0-5161"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamangar</surname><given-names>F</given-names></name><name><surname>Dawsey</surname><given-names>SM</given-names></name><name><surname>Blaser</surname><given-names>MJ</given-names></name><name><surname>Perez-Perez</surname><given-names>GI</given-names></name><name><surname>Pietinen</surname><given-names>P</given-names></name><name><surname>Newschaffer</surname><given-names>CJ</given-names></name><name><surname>Abnet</surname><given-names>CC</given-names></name><name><surname>Albanes</surname><given-names>D</given-names></name><name><surname>Virtamo</surname><given-names>J</given-names></name><name><surname>Taylor</surname><given-names>PR</given-names></name></person-group><article-title>Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity</article-title><source>J Natl Cancer Inst</source><volume>98</volume><fpage>1445</fpage><lpage>1452</lpage><year>2006</year><pub-id pub-id-type="doi">10.1093/jnci/djj393</pub-id><?supplied-pmid 17047193?><pub-id pub-id-type="pmid">17047193</pub-id></element-citation></ref><ref id="b7-ol-0-0-5161"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>MA</given-names></name><name><surname>Lee</surname><given-names>HS</given-names></name><name><surname>Yang</surname><given-names>HK</given-names></name><name><surname>Kim</surname><given-names>WH</given-names></name></person-group><article-title>Clinicopathologic and protein expression differences between cardia carcinoma and noncardia carcinoma of the stomach</article-title><source>Cancer</source><volume>103</volume><fpage>1439</fpage><lpage>1446</lpage><year>2005</year><pub-id pub-id-type="doi">10.1002/cncr.20966</pub-id><?supplied-pmid 15726543?><pub-id pub-id-type="pmid">15726543</pub-id></element-citation></ref><ref id="b8-ol-0-0-5161"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ziogas</surname><given-names>D</given-names></name><name><surname>Baltogiannis</surname><given-names>G</given-names></name><name><surname>Fatouros</surname><given-names>M</given-names></name><name><surname>Roukos</surname><given-names>DH</given-names></name></person-group><article-title>Identifying and preventing high-risk gastric cancer individuals with CDH1 mutations</article-title><source>Ann Surg</source><volume>247</volume><fpage>714</fpage><lpage>715</lpage><comment>author reply 715&#8211;716</comment><year>2008</year><pub-id pub-id-type="doi">10.1097/SLA.0b013e31816a5072</pub-id><?supplied-pmid 18362641?><pub-id pub-id-type="pmid">18362641</pub-id></element-citation></ref><ref id="b9-ol-0-0-5161"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norton</surname><given-names>JA</given-names></name><name><surname>Ham</surname><given-names>CM</given-names></name><name><surname>Van Dam</surname><given-names>J</given-names></name><name><surname>Jeffrey</surname><given-names>RB</given-names></name><name><surname>Longacre</surname><given-names>TA</given-names></name><name><surname>Huntsman</surname><given-names>DG</given-names></name><name><surname>Chun</surname><given-names>N</given-names></name><name><surname>Kurian</surname><given-names>AW</given-names></name><name><surname>Ford</surname><given-names>JM</given-names></name></person-group><article-title>CDH1 truncating mutations in the E-cadherin gene: An indication for total gastrectomy to treat hereditary diffuse gastric cancer</article-title><source>Ann Surg</source><volume>245</volume><fpage>873</fpage><lpage>879</lpage><year>2007</year><pub-id pub-id-type="doi">10.1097/01.sla.0000254370.29893.e4</pub-id><?supplied-pmid 17522512?><pub-id pub-id-type="pmid">17522512</pub-id></element-citation></ref><ref id="b10-ol-0-0-5161"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Tao</surname><given-names>Q</given-names></name><name><surname>Cheng</surname><given-names>YY</given-names></name><name><surname>Lee</surname><given-names>KY</given-names></name><name><surname>Ng</surname><given-names>SS</given-names></name><name><surname>Cheung</surname><given-names>KF</given-names></name><name><surname>Tian</surname><given-names>L</given-names></name><name><surname>Rha</surname><given-names>SY</given-names></name><name><surname>Neumann</surname><given-names>U</given-names></name><name><surname>R&#246;cken</surname><given-names>C</given-names></name><etal/></person-group><article-title>Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer</article-title><source>Cancer</source><volume>115</volume><fpage>49</fpage><lpage>60</lpage><year>2009</year><pub-id pub-id-type="doi">10.1002/cncr.23989</pub-id><?supplied-pmid 19051296?><pub-id pub-id-type="pmid">19051296</pub-id></element-citation></ref><ref id="b11-ol-0-0-5161"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>HJ</given-names></name><name><surname>Nam</surname><given-names>KT</given-names></name><name><surname>Park</surname><given-names>HS</given-names></name><name><surname>Kim</surname><given-names>MA</given-names></name><name><surname>Lafleur</surname><given-names>BJ</given-names></name><name><surname>Aburatani</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>HK</given-names></name><name><surname>Kim</surname><given-names>WH</given-names></name><name><surname>Goldenring</surname><given-names>JR</given-names></name></person-group><article-title>Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer</article-title><source>Gastroenterology</source><volume>139</volume><fpage>213</fpage><lpage>225</lpage><year>2010</year><pub-id pub-id-type="doi">10.1053/j.gastro.2010.04.008</pub-id><?supplied-pmid 20398667?><pub-id pub-id-type="pmid">20398667</pub-id></element-citation></ref><ref id="b12-ol-0-0-5161"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engelman</surname><given-names>JA</given-names></name><name><surname>Zejnullahu</surname><given-names>K</given-names></name><name><surname>Mitsudomi</surname><given-names>T</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Hyland</surname><given-names>C</given-names></name><name><surname>Park</surname><given-names>JO</given-names></name><name><surname>Lindeman</surname><given-names>N</given-names></name><name><surname>Gale</surname><given-names>CM</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Christensen</surname><given-names>J</given-names></name><etal/></person-group><article-title>MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling</article-title><source>Science</source><volume>316</volume><fpage>1039</fpage><lpage>1043</lpage><year>2007</year><pub-id pub-id-type="doi">10.1126/science.1141478</pub-id><?supplied-pmid 17463250?><pub-id pub-id-type="pmid">17463250</pub-id></element-citation></ref><ref id="b13-ol-0-0-5161"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>YR</given-names></name><name><surname>Juan</surname><given-names>HF</given-names></name><name><surname>Huang</surname><given-names>HC</given-names></name><name><surname>Huang</surname><given-names>HH</given-names></name><name><surname>Lee</surname><given-names>YJ</given-names></name><name><surname>Liao</surname><given-names>MY</given-names></name><name><surname>Tseng</surname><given-names>CW</given-names></name><name><surname>Lin</surname><given-names>LL</given-names></name><name><surname>Chen</surname><given-names>JY</given-names></name><name><surname>Wang</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells</article-title><source>J Proteome Res</source><volume>5</volume><fpage>2727</fpage><lpage>2742</lpage><year>2006</year><pub-id pub-id-type="doi">10.1021/pr060212g</pub-id><?supplied-pmid 17022644?><pub-id pub-id-type="pmid">17022644</pub-id></element-citation></ref><ref id="b14-ol-0-0-5161"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>CN</given-names></name><name><surname>Lin</surname><given-names>JJ</given-names></name><name><surname>Chen</surname><given-names>JJ</given-names></name><name><surname>Lee</surname><given-names>PH</given-names></name><name><surname>Yang</surname><given-names>CY</given-names></name><name><surname>Kuo</surname><given-names>ML</given-names></name><name><surname>Chang</surname><given-names>KJ</given-names></name><name><surname>Hsieh</surname><given-names>FJ</given-names></name></person-group><article-title>Gene expression profile predicts patient survival of gastric cancer after surgical resection</article-title><source>J Clin Oncol</source><volume>23</volume><fpage>7286</fpage><lpage>7295</lpage><year>2005</year><pub-id pub-id-type="doi">10.1200/JCO.2004.00.2253</pub-id><?supplied-pmid 16145069?><pub-id pub-id-type="pmid">16145069</pub-id></element-citation></ref><ref id="b15-ol-0-0-5161"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Hu</surname><given-names>N</given-names></name><name><surname>Yang</surname><given-names>HH</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Su</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Clifford</surname><given-names>R</given-names></name><name><surname>Dawsey</surname><given-names>EM</given-names></name><name><surname>Li</surname><given-names>JM</given-names></name><name><surname>Ding</surname><given-names>T</given-names></name><etal/></person-group><article-title>Comparison of global gene expression of gastric cardia and noncardia cancers from a high-risk population in China</article-title><source>PLoS One</source><volume>8</volume><fpage>e63826</fpage><year>2013</year><pub-id pub-id-type="doi">10.1371/journal.pone.0063826</pub-id><?supplied-pmid 23717493?><pub-id pub-id-type="pmid">23717493</pub-id></element-citation></ref><ref id="b16-ol-0-0-5161"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irizarry</surname><given-names>RA</given-names></name><name><surname>Hobbs</surname><given-names>B</given-names></name><name><surname>Collin</surname><given-names>F</given-names></name><name><surname>Beazer-Barclay</surname><given-names>YD</given-names></name><name><surname>Antonellis</surname><given-names>KJ</given-names></name><name><surname>Scherf</surname><given-names>U</given-names></name><name><surname>Speed</surname><given-names>TP</given-names></name></person-group><article-title>Exploration, normalization and summaries of high density oligonucleotide array probe level data</article-title><source>Biostatistics</source><volume>4</volume><fpage>249</fpage><lpage>264</lpage><year>2003</year><pub-id pub-id-type="doi">10.1093/biostatistics/4.2.249</pub-id><?supplied-pmid 12925520?><pub-id pub-id-type="pmid">12925520</pub-id></element-citation></ref><ref id="b17-ol-0-0-5161"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group><article-title>Linear models and empirical bayes methods for assessing differential expression in microarray experiments</article-title><source>Stat Appl Genet Mol Biol</source><volume>3</volume><comment>Article 3</comment><year>2004</year><?supplied-pmid 16646809?><pub-id pub-id-type="pmid">16646809</pub-id></element-citation></ref><ref id="b18-ol-0-0-5161"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>DW</given-names></name><name><surname>Sherman</surname><given-names>BT</given-names></name><name><surname>Tan</surname><given-names>Q</given-names></name><name><surname>Collins</surname><given-names>JR</given-names></name><name><surname>Alvord</surname><given-names>WG</given-names></name><name><surname>Roayaei</surname><given-names>J</given-names></name><name><surname>Stephens</surname><given-names>R</given-names></name><name><surname>Baseler</surname><given-names>MW</given-names></name><name><surname>Lane</surname><given-names>HC</given-names></name><name><surname>Lempicki</surname><given-names>RA</given-names></name></person-group><article-title>The DAVID gene functional classification tool: A novel biological module-centric algorithm to functionally analyze large gene lists</article-title><source>Genome Biol</source><volume>8</volume><fpage>R183</fpage><year>2007</year><pub-id pub-id-type="doi">10.1186/gb-2007-8-9-r183</pub-id><?supplied-pmid 17784955?><pub-id pub-id-type="pmid">17784955</pub-id></element-citation></ref><ref id="b19-ol-0-0-5161"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franceschini</surname><given-names>A</given-names></name><name><surname>Szklarczyk</surname><given-names>D</given-names></name><name><surname>Frankild</surname><given-names>S</given-names></name><name><surname>Kuhn</surname><given-names>M</given-names></name><name><surname>Simonovic</surname><given-names>M</given-names></name><name><surname>Roth</surname><given-names>A</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Minguez</surname><given-names>P</given-names></name><name><surname>Bork</surname><given-names>P</given-names></name><name><surname>von Mering</surname><given-names>C</given-names></name><name><surname>Jensen</surname><given-names>LJ</given-names></name></person-group><article-title>STRING v9.1: Protein-protein interaction networks, with increased coverage and integration</article-title><source>Nucleic Acids Res</source><volume>41</volume><fpage>D808</fpage><lpage>D815</lpage><year>2013</year><pub-id pub-id-type="doi">10.1093/nar/gks1094</pub-id><?supplied-pmid 23203871?><pub-id pub-id-type="pmid">23203871</pub-id></element-citation></ref><ref id="b20-ol-0-0-5161"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohl</surname><given-names>M</given-names></name><name><surname>Wiese</surname><given-names>S</given-names></name><name><surname>Warscheid</surname><given-names>B</given-names></name></person-group><article-title>Cytoscape: Software for visualization and analysis of biological networks</article-title><source>Methods Mol Biol</source><volume>696</volume><fpage>291</fpage><lpage>303</lpage><year>2011</year><pub-id pub-id-type="doi">10.1007/978-1-60761-987-1_18</pub-id><?supplied-pmid 21063955?><pub-id pub-id-type="pmid">21063955</pub-id></element-citation></ref><ref id="b21-ol-0-0-5161"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bader</surname><given-names>GD</given-names></name><name><surname>Hogue</surname><given-names>CW</given-names></name></person-group><article-title>An automated method for finding molecular complexes in large protein interaction networks</article-title><source>BMC Bioinformatics</source><volume>4</volume><fpage>2</fpage><year>2003</year><pub-id pub-id-type="doi">10.1186/1471-2105-4-2</pub-id><?supplied-pmid 12525261?><pub-id pub-id-type="pmid">12525261</pub-id></element-citation></ref><ref id="b22-ol-0-0-5161"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>AH</given-names></name><name><surname>Frierson</surname><given-names>HF</given-names></name><name><surname>Zaika</surname><given-names>A</given-names></name><name><surname>Powell</surname><given-names>SM</given-names></name><name><surname>Roche</surname><given-names>J</given-names></name><name><surname>Crowe</surname><given-names>S</given-names></name><name><surname>Moskaluk</surname><given-names>CA</given-names></name><name><surname>El-Rifai</surname><given-names>W</given-names></name></person-group><article-title>Expression of tight-junction protein claudin-7 is an early event in gastric tumorigenesis</article-title><source>Am J Pathol</source><volume>167</volume><fpage>577</fpage><lpage>584</lpage><year>2005</year><pub-id pub-id-type="doi">10.1016/S0002-9440(10)62999-9</pub-id><?supplied-pmid 16049341?><pub-id pub-id-type="pmid">16049341</pub-id></element-citation></ref><ref id="b23-ol-0-0-5161"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zavala-Zendejas</surname><given-names>VE</given-names></name><name><surname>Torres-Martinez</surname><given-names>AC</given-names></name><name><surname>Salas-Morales</surname><given-names>B</given-names></name><name><surname>Fortoul</surname><given-names>TI</given-names></name><name><surname>Monta&#241;o</surname><given-names>LF</given-names></name><name><surname>Rendon-Huerta</surname><given-names>EP</given-names></name></person-group><article-title>Claudin-6, 7, or 9 overexpression in the human gastric adenocarcinoma cell line AGS increases its invasiveness, migration, and proliferation rate</article-title><source>Cancer Invest</source><volume>29</volume><fpage>1</fpage><lpage>11</lpage><year>2011</year><pub-id pub-id-type="doi">10.3109/07357907.2010.512594</pub-id><?supplied-pmid 20874001?><pub-id pub-id-type="pmid">20874001</pub-id></element-citation></ref><ref id="b24-ol-0-0-5161"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>QS</given-names></name><name><surname>Dong</surname><given-names>WG</given-names></name></person-group><article-title>Blockade of proliferation and migration of gastric cancer via targeting CDH17 with an artificial microRNA</article-title><source>Med Oncol</source><volume>28</volume><fpage>494</fpage><lpage>501</lpage><year>2011</year><pub-id pub-id-type="doi">10.1007/s12032-010-9489-0</pub-id><?supplied-pmid 20393816?><pub-id pub-id-type="pmid">20393816</pub-id></element-citation></ref><ref id="b25-ol-0-0-5161"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>P</given-names></name><name><surname>Weaver</surname><given-names>VM</given-names></name><name><surname>Werb</surname><given-names>Z</given-names></name></person-group><article-title>The extracellular matrix: A dynamic niche in cancer progression</article-title><source>J Cell Biol</source><volume>196</volume><fpage>395</fpage><lpage>406</lpage><year>2012</year><pub-id pub-id-type="doi">10.1083/jcb.201102147</pub-id><?supplied-pmid 22351925?><pub-id pub-id-type="pmid">22351925</pub-id></element-citation></ref><ref id="b26-ol-0-0-5161"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stetler-Stevenson</surname><given-names>WG</given-names></name><name><surname>Aznavoorian</surname><given-names>S</given-names></name><name><surname>Liotta</surname><given-names>LA</given-names></name></person-group><article-title>Tumor cell interactions with the extracellular matrix during invasion and metastasis</article-title><source>Annu Rev Cell Biol</source><volume>9</volume><fpage>541</fpage><lpage>573</lpage><year>1993</year><pub-id pub-id-type="doi">10.1146/annurev.cb.09.110193.002545</pub-id><?supplied-pmid 8280471?><pub-id pub-id-type="pmid">8280471</pub-id></element-citation></ref><ref id="b27-ol-0-0-5161"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>David</surname><given-names>L</given-names></name><name><surname>Nesland</surname><given-names>JM</given-names></name><name><surname>Holm</surname><given-names>R</given-names></name><name><surname>Sobrinho-Sim&#245;es</surname><given-names>M</given-names></name></person-group><article-title>Expression of laminin, collagen IV, fibronectin, and type IV collagenase in gastric carcinoma. An immunohistochemical study of 87 patients</article-title><source>Cancer</source><volume>73</volume><fpage>518</fpage><lpage>527</lpage><year>1994</year><pub-id pub-id-type="doi">10.1002/1097-0142(19940201)73:3&lt;518::AID-CNCR2820730305&gt;3.0.CO;2-T</pub-id><?supplied-pmid 8299074?><pub-id pub-id-type="pmid">8299074</pub-id></element-citation></ref><ref id="b28-ol-0-0-5161"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Gang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Luo</surname><given-names>T</given-names></name><name><surname>Wen</surname><given-names>F</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name></person-group><article-title>Up-regulation of gastric cancer cell invasion by Twist is accompanied by N-cadherin and fibronectin expression</article-title><source>Biochem Biophys Res Commun</source><volume>358</volume><fpage>925</fpage><lpage>930</lpage><year>2007</year><pub-id pub-id-type="doi">10.1016/j.bbrc.2007.05.023</pub-id><?supplied-pmid 17512904?><pub-id pub-id-type="pmid">17512904</pub-id></element-citation></ref><ref id="b29-ol-0-0-5161"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coe</surname><given-names>BP</given-names></name><name><surname>Lee</surname><given-names>EH</given-names></name><name><surname>Chi</surname><given-names>B</given-names></name><name><surname>Girard</surname><given-names>L</given-names></name><name><surname>Minna</surname><given-names>JD</given-names></name><name><surname>Gazdar</surname><given-names>AF</given-names></name><name><surname>Lam</surname><given-names>S</given-names></name><name><surname>MacAulay</surname><given-names>C</given-names></name><name><surname>Lam</surname><given-names>WL</given-names></name></person-group><article-title>Gain of a region on 7p22.3, containing MAD1L1, is the most frequent event in small-cell lung cancer cell lines</article-title><source>Genes Chromosomes Cancer</source><volume>45</volume><fpage>11</fpage><lpage>19</lpage><year>2006</year><pub-id pub-id-type="doi">10.1002/gcc.20260</pub-id><?supplied-pmid 16130125?><pub-id pub-id-type="pmid">16130125</pub-id></element-citation></ref><ref id="b30-ol-0-0-5161"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Miao</surname><given-names>X</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Yao</surname><given-names>J</given-names></name><name><surname>Tan</surname><given-names>W</given-names></name><name><surname>Sun</surname><given-names>T</given-names></name><name><surname>Zhao</surname><given-names>D</given-names></name><name><surname>Yu</surname><given-names>D</given-names></name><etal/></person-group><article-title>Functional evaluation of missense variations in the human MAD1L1 and MAD2L1 genes and their impact on susceptibility to lung cancer</article-title><source>J Med Genet</source><volume>47</volume><fpage>616</fpage><lpage>622</lpage><year>2010</year><pub-id pub-id-type="doi">10.1136/jmg.2009.074252</pub-id><?supplied-pmid 20516147?><pub-id pub-id-type="pmid">20516147</pub-id></element-citation></ref><ref id="b31-ol-0-0-5161"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Begnami</surname><given-names>MD</given-names></name><name><surname>Fregnani</surname><given-names>JH</given-names></name><name><surname>Nonogaki</surname><given-names>S</given-names></name><name><surname>Soares</surname><given-names>FA</given-names></name></person-group><article-title>Evaluation of cell cycle protein expression in gastric cancer: Cyclin B1 expression and its prognostic implication</article-title><source>Hum Pathol</source><volume>41</volume><fpage>1120</fpage><lpage>1127</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.humpath.2010.01.007</pub-id><?supplied-pmid 20334896?><pub-id pub-id-type="pmid">20334896</pub-id></element-citation></ref><ref id="b32-ol-0-0-5161"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-azzeh</surname><given-names>ED</given-names></name><name><surname>Fegert</surname><given-names>P</given-names></name><name><surname>Blin</surname><given-names>N</given-names></name><name><surname>G&#246;tt</surname><given-names>P</given-names></name></person-group><article-title>Transcription factor GATA-6 activates expression of gastroprotective trefoil genes TFF1 and TFF2</article-title><source>Biochim Biophys Acta</source><volume>1490</volume><fpage>324</fpage><lpage>332</lpage><year>2000</year><pub-id pub-id-type="doi">10.1016/S0167-4781(00)00013-0</pub-id><?supplied-pmid 10684977?><pub-id pub-id-type="pmid">10684977</pub-id></element-citation></ref><ref id="b33-ol-0-0-5161"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haveri</surname><given-names>H</given-names></name><name><surname>Westerholm-Ormio</surname><given-names>M</given-names></name><name><surname>Lindfors</surname><given-names>K</given-names></name><name><surname>M&#228;ki</surname><given-names>M</given-names></name><name><surname>Savilahti</surname><given-names>E</given-names></name><name><surname>Andersson</surname><given-names>LC</given-names></name><name><surname>Heikinheimo</surname><given-names>M</given-names></name></person-group><article-title>Transcription factors GATA-4 and GATA-6 in normal and neoplastic human gastrointestinal mucosa</article-title><source>BMC Gastroenterol</source><volume>8</volume><fpage>9</fpage><year>2008</year><pub-id pub-id-type="doi">10.1186/1471-230X-8-9</pub-id><?supplied-pmid 18405344?><pub-id pub-id-type="pmid">18405344</pub-id></element-citation></ref><ref id="b34-ol-0-0-5161"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Posey</surname><given-names>JT</given-names></name><name><surname>Soloway</surname><given-names>MS</given-names></name><name><surname>Ekici</surname><given-names>S</given-names></name><name><surname>Sofer</surname><given-names>M</given-names></name><name><surname>Civantos</surname><given-names>F</given-names></name><name><surname>Duncan</surname><given-names>RC</given-names></name><name><surname>Lokeshwar</surname><given-names>VB</given-names></name></person-group><article-title>Evaluation of the prognostic potential of hyaluronic acid and hyaluronidase (HYAL1) for prostate cancer</article-title><source>Cancer Res</source><volume>63</volume><fpage>2638</fpage><lpage>2644</lpage><year>2003</year><?supplied-pmid 12750291?><pub-id pub-id-type="pmid">12750291</pub-id></element-citation></ref><ref id="b35-ol-0-0-5161"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lokeshwar</surname><given-names>VB</given-names></name><name><surname>Cerwinka</surname><given-names>WH</given-names></name><name><surname>Isoyama</surname><given-names>T</given-names></name><name><surname>Lokeshwar</surname><given-names>BL</given-names></name></person-group><article-title>HYAL1 hyaluronidase in prostate cancer: A tumor promoter and suppressor</article-title><source>Cancer Res</source><volume>65</volume><fpage>7782</fpage><lpage>7789</lpage><year>2005</year><?supplied-pmid 16140946?><pub-id pub-id-type="pmid">16140946</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="f1-ol-0-0-5161" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Box plots of gene expression data of GCA and normal control (A) prior to and (B) after normalization. GCA samples are in blue, while normal controls are in red. Black lines in the boxes represent medians. GCA, gastric cardia adenocarcinoma.</p></caption><graphic xlink:href="ol-12-05-3866-g00"/></fig><fig id="f2-ol-0-0-5161" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>Box plots of gene expression data of GNCA and normal control (A) prior to and (B) after normalization. GNCA samples are in blue, while normal controls are in red. Black lines in the boxes represent medians. GNCA, gastric non-cardia adenocarcinoma.</p></caption><graphic xlink:href="ol-12-05-3866-g01"/></fig><fig id="f3-ol-0-0-5161" orientation="portrait" position="float"><label>Figure 3.</label><caption><p>Venn diagram describing the number of differentially-expressed genes in gastric cardia adenocarcinoma (GCA) and gastric non-cardia adenocarcinoma (GNCA). Arrows represent regulation.</p></caption><graphic xlink:href="ol-12-05-3866-g02"/></fig><fig id="f4-ol-0-0-5161" orientation="portrait" position="float"><label>Figure 4.</label><caption><p>Protein-protein interaction network for the common differentially-expressed genes. Upregulated genes are in red, while downregulated genes are in green.</p></caption><graphic xlink:href="ol-12-05-3866-g03"/></fig><fig id="f5-ol-0-0-5161" orientation="portrait" position="float"><label>Figure 5.</label><caption><p>Two subnetworks extracted from the whole protein-protein interaction network.</p></caption><graphic xlink:href="ol-12-05-3866-g04"/></fig><table-wrap id="tI-ol-0-0-5161" orientation="portrait" position="float"><label>Table I.</label><caption><p>Functional enrichment analysis for common differentially-expressed genes.</p></caption><table-wrap-foot><fn id="tfn1-ol-0-0-5161"><p>GO, Gene Ontology; BP, biological process; CC, cellular component; MF, molecular function; KEGG, Kyoto Encyclopedia of Genes and Genomes; ECM, extracellular matrix.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tII-ol-0-0-5161" orientation="portrait" position="float"><label>Table II.</label><caption><p>Functional enrichment analysis for unique differentially-expressed genes in gastric cardia adenocarcinoma.</p></caption><table-wrap-foot><fn id="tfn2-ol-0-0-5161"><p>GO, Gene Ontology; BP, biological process; CC, cellular component; MF, molecular function; KEGG, Kyoto Encyclopedia of Genes and Genomes.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tIII-ol-0-0-5161" orientation="portrait" position="float"><label>Table III.</label><caption><p>Functional enrichment analysis for unique differentially-expressed genes in gastric non-cardia adenocarcinoma.</p></caption><table-wrap-foot><fn id="tfn3-ol-0-0-5161"><p>GO, Gene Ontology; BP, biological process; CC, cellular component; MF, molecular function; KEGG, Kyoto Encyclopedia of Genes and Genomes; GTP, guanosine triphosphate.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tIV-ol-0-0-5161" orientation="portrait" position="float"><label>Table IV.</label><caption><p>Functional enrichment analysis result for genes from subnetwork 1.</p></caption><table-wrap-foot><fn id="tfn4-ol-0-0-5161"><p>GO, Gene Ontology; BP, biological process; CC, cellular component; MF, molecular function; KEGG, Kyoto Encyclopedia of Genes and Genomes; ECM, extracellular matrix; SMAD</p></fn></table-wrap-foot></table-wrap><table-wrap id="tV-ol-0-0-5161" orientation="portrait" position="float"><label>Table V.</label><caption><p>Functional enrichment analysis result for genes from subnetwork 2.</p></caption><table-wrap-foot><fn id="tfn5-ol-0-0-5161"><p>GO, Gene Ontology; BP, biological process; CC, cellular component; MF, molecular function; KEGG, Kyoto Encyclopedia of Genes and Genomes; ECM, extracellular matrix.</p></fn></table-wrap-foot></table-wrap></floats-group></article>